Article R754-3
…312-9 and R. 312-10no. 2020-1565 of 10 December 2020R. 312-11No. 2014-737 of 30 June 2014R. 312-12n° 2020-1565 of 10 December 2020R. 312-13 to R. 312-17n° 2014-737 of 30 June 2014R. 312-18, with the…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 6011–6020 of 26420 articles for “Art. Cass. 3e civ. 19-11-2014 n° 13-20.089”
…312-9 and R. 312-10no. 2020-1565 of 10 December 2020R. 312-11No. 2014-737 of 30 June 2014R. 312-12n° 2020-1565 of 10 December 2020R. 312-13 to R. 312-17n° 2014-737 of 30 June 2014R. 312-18, with the…
…312-9 and R. 312-10no. 2020-1565 of 10 December 2020R. 312-11No. 2014-737 of 30 June 2014R. 312-12n° 2020-1565 of 10 December 2020R. 312-13 to R. 312-17n° 2014-737 of 30 June 2014R. 312-18, with the…
The information provided for in Articles R. 5121-138 and R. 5121-139 is written in French. They may also be written in other languages, provided that the same information appears in all the languages…
Ampoules or other small primary packaging on which it is impossible to include all the information specified in Article R. 5121-138 may bear only the following information: 1° The name of the medicina…
By way of derogation from the provisions of Article R. 5121-138, when the medicinal products or products are contained in an outer packaging that complies with the requirements of the said Article, th…
The articles listed in the left-hand column of the table below shall apply in the Wallis and Futuna Islands in the wording indicated in the right-hand column of the same table: Articles applicable In…
Pharmacovigilance is carried out :1° For medicinal products and for products which must be covered by the marketing authorisation provided for in article L. 5121-8, after this authorisation has been i…
For the purposes of this chapter, the following definitions shall apply 1° "Adverse reaction": a noxious and unintended response to a medicinal product or to a product mentioned in Article R. 5121-150…
Pharmacovigilance includes: 1° The reporting of adverse reactions suspected to be due to a medicinal product or a product mentioned in article R. 5121-150, including cases of overdose, misuse, abuse a…
Without prejudice to the provisions of Article R. 5132-15, the labelling of the immediate packaging and, if available, the outer packaging of the preparations mentioned in 1° to 3° of Article L. 5121-…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More